Wuhan General Group (China), Inc. (WUHN)
WUHN Stock Price Chart
Explore Wuhan General Group (China), Inc. interactive price chart. Choose custom timeframes to analyze WUHN price movements and trends.
WUHN Company Profile
Discover essential business fundamentals and corporate details for Wuhan General Group (China), Inc. (WUHN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
19 Apr 2006
Employees
700.00
Website
https://wuhn.orgCEO
Jeffrey Robinson
Description
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
WUHN Financial Timeline
Browse a chronological timeline of Wuhan General Group (China), Inc. corporate events including earnings releases, dividend announcements, and stock splits.
WUHN Stock Performance
Access detailed WUHN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.